POLX Stock Overview
Operates as a drug-device manufacturer and service provider for noble gas polarizer devices in Canada, the United Kingdom, and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Polarean Imaging plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.016 |
| 52 Week High | UK£0.24 |
| 52 Week Low | UK£0.01 |
| Beta | 0.39 |
| 11 Month Change | 30.00% |
| 3 Month Change | -58.33% |
| 1 Year Change | -93.09% |
| 33 Year Change | -98.26% |
| 5 Year Change | -91.67% |
| Change since IPO | -89.84% |
Recent News & Updates
Recent updates
Here's Why Polarean Imaging (LON:POLX) Must Use Its Cash Wisely
Jan 09
Is Polarean Imaging (LON:POLX) In A Good Position To Invest In Growth?
Sep 11Is Polarean Imaging (LON:POLX) In A Good Position To Invest In Growth?
Feb 09We're Keeping An Eye On Polarean Imaging's (LON:POLX) Cash Burn Rate
Oct 09Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans
Dec 15We Think Shareholders Will Probably Be Generous With Polarean Imaging plc's (LON:POLX) CEO Compensation
Jul 07Here's Why We're Watching Polarean Imaging's (LON:POLX) Cash Burn Situation
Jun 07Insider Buying: The Polarean Imaging plc (LON:POLX) Independent Chairman Just Bought 6.6% More Shares
Mar 18Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans
Mar 09Polarean Imaging (LON:POLX) Shareholders Have Enjoyed An Impressive 135% Share Price Gain
Feb 01
Should You Take Comfort From Insider Transactions At Polarean Imaging plc (LON:POLX)?
Dec 28What Type Of Shareholders Own The Most Number of Polarean Imaging plc (LON:POLX) Shares?
Nov 30Shareholder Returns
| POLX | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -1.5% | 5.3% | 0.8% |
| 1Y | -93.1% | -2.7% | 10.9% |
Return vs Industry: POLX underperformed the UK Medical Equipment industry which returned -3.1% over the past year.
Return vs Market: POLX underperformed the UK Market which returned 10.8% over the past year.
Price Volatility
| POLX volatility | |
|---|---|
| POLX Average Weekly Movement | 24.4% |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: POLX's share price has been volatile over the past 3 months.
Volatility Over Time: POLX's weekly volatility has increased from 17% to 24% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 29 | Chris Von Jako | polarean.com |
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas polarizer devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; and measurement station, chest coil, and dose delivery inhalation bags.
Polarean Imaging plc Fundamentals Summary
| POLX fundamental statistics | |
|---|---|
| Market cap | UK£19.61m |
| Earnings (TTM) | -UK£9.27m |
| Revenue (TTM) | UK£695.17k |
28.2x
P/S Ratio-2.1x
P/E RatioIs POLX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| POLX income statement (TTM) | |
|---|---|
| Revenue | US$890.93k |
| Cost of Revenue | US$555.45k |
| Gross Profit | US$335.48k |
| Other Expenses | US$12.22m |
| Earnings | -US$11.88m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0098 |
| Gross Margin | 37.66% |
| Net Profit Margin | -1,333.97% |
| Debt/Equity Ratio | 0% |
How did POLX perform over the long term?
See historical performance and comparison